Founded in 2015, Triastek, Inc. is the global leader in the 3D printing of pharmaceuticals and is pioneering the implementation of digital pharmaceutical solutions. Triastek’s novel and proprietary 3D printing technology platform, encompasses dosage form design, digital pharmaceutical product development, and intelligent manufacturing. Triastek has the largest product pipeline based on 3D printing technology in the world, with the company’s 1st and 2nd products (T19 and T20) having received IND clearance from the U.S. Food and Drug Administration (FDA). The company also holds the highest number of patent applications related to 3D printing of pharmaceuticals, providing the most comprehensive patent coverage of any 3D printing pharmaceutical company in the world.